自身免疫性脑炎的免疫治疗和预后  

Immunotherapy and prognosis of autoimmune encephalitis

作　　者：何芳[1] 彭镜[1] 杨丽芬[1] 吴丽文[1] 邓小鹿[1] 张慈柳[1] 尹飞[1] He Fang;Peng Jing;Yang Lifen;Wu Liwen;Deng Xiaolu;Zhang Ciliu;Yin Fei(Department of Pediatrics,Xiangya Hospital,Central South University,Changsha 410008,China)

机构地区：[1]中南大学湘雅医院儿科,长沙410008

出　　处：《中华实用儿科临床杂志》2019年第24期1855-1857,共3页Chinese Journal of Applied Clinical Pediatrics

基　　金：国家自然科学基金(81771409,81771408,81301031)。

摘　　要：自身免疫性脑炎(AE)是当今儿童神经病学中备受关注及进展最快的领域之一。免疫治疗是AE最重要的治疗手段,免疫治疗延迟或不使用免疫疗法可导致AE患者预后不良。现总结目前AE免疫治疗的方案及预后影响因素,以期对临床医师进行AE的治疗决策提供指导。Autoimmune encephalitis(AE)is one of the most rapidly developing research fields in pediatric neurology.Previous studies have indicated that delayed-use or non-use of immunotherapy will lead to poor prognosis.Therefore,this article summarizes the current opinion of immunotherapy and prognostic factors for AE in order to provide treatment guidance for clinicians.

关 键 词：自身免疫性脑炎 治疗 预后 

分 类 号：R742[医药卫生—神经病学与精神病学]